Literature DB >> 15648612

Molecular study of clonality in multifocal and bilateral breast tumors.

Neelanjana Chunder1, Anup Roy, Susanta Roychoudhury, Chinmay Kumar Panda.   

Abstract

The clonal origin of multiple tumors in the same individual has long been debated. The main aim of this study is to find out whether multiple tumors in same individuals originated from a single clone. In our previous work (Pathol. Res. Pract. 199 (2003) 313-321), the deletion at chromosome1p36 was found to occur early because of common allelic loss in the bilateral tumors. In order to further investigate the findings about the clonality of tumors, eight tumors from four patients (two synchronous bilateral breast carcinoma [biBC], one case with breast carcinoma in one breast and multiple calcified fibroadenoma nodules in another breast, and one case with multifocal fibroadenosis in one breast) were subjected to polymerase chain reaction (PCR) to detect (a) loss of heterozygosity (LOH) and microsatellite size alterations (MA) using microsatellite markers distributed over five chromosomal arms 11p/q, 13q and 17p/q, and (b) Cyclin D1 amplification. Some markers were intragenic for BRCA1, BRCA2, BRCAX, ATM, TP53, and RB1. Although a few cases were studied, our findings suggest that in at least a proportion of patients multiple tumors may arise from a single clone.

Entities:  

Mesh:

Year:  2004        PMID: 15648612     DOI: 10.1016/j.prp.2004.09.001

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge.

Authors:  Irina Ostrovnaya; Colin B Begg
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

2.  Contralateral breast cancers: Independent cancers or metastases?

Authors:  Colin B Begg; Irina Ostrovnaya; Felipe C Geyer; Anastasios D Papanastasiou; Charlotte K Y Ng; Rita A Sakr; Jonine L Bernstein; Kathleen A Burke; Tari A King; Salvatore Piscuoglio; Audrey Mauguen; Irene Orlow; Britta Weigelt; Venkatraman E Seshan; Monica Morrow; Jorge S Reis-Filho
Journal:  Int J Cancer       Date:  2017-09-28       Impact factor: 7.396

3.  Challenges of treating incidental synchronous bilateral breast cancer with differing tumour biology.

Authors:  Jonathan Walter Esclovon; Melissa Ponder; Nail Aydin; Subhasis Misra
Journal:  BMJ Case Rep       Date:  2016-08-18

4.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

5.  Statistical tests for clonality.

Authors:  Colin B Begg; Kevin H Eng; Amanda J Hummer
Journal:  Biometrics       Date:  2007-06       Impact factor: 2.571

6.  Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.

Authors:  Arezou A Ghazani; Nona Arneson; Keisha Warren; Melania Pintilie; Jane Bayani; Jeremy A Squire; Susan J Done
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

7.  Comparative genomic analysis reveals bilateral breast cancers are genetically independent.

Authors:  Fangfang Song; Xiangchun Li; Fengju Song; Yanrui Zhao; Haixin Li; Hong Zheng; Zhibo Gao; Jun Wang; Wei Zhang; Kexin Chen
Journal:  Oncotarget       Date:  2015-10-13

8.  Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.

Authors:  Lei Bao; Karen Messer; Richard Schwab; Olivier Harismendy; Minya Pu; Brian Crain; Shawn Yost; Kelly A Frazer; Brinda Rana; Farnaz Hasteh; Anne Wallace; Barbara A Parker
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.